Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019813 220018091 null 59 Not known (9) 2017-12-11 2018-01-05 Arsenic trioxide null null 220033933 LENALIDOMIDE
220019814 220009004 1.7 93.6 Disease modification (D) 2015-02-22 2015-05-16 AML Relapsed FLA 2 N 220033943 MACE
220019815 220009005 1.4 55 Not known (9) null 2014-05-10 TRASTUZUMAB Y N 220033951 TRASTUZUMAB
220019816 220009008 null null null 2014-06-05 2014-06-18 LENALIDOMIDE N N 220033957 TIP
220019817 220014813 null null Disease modification (D) null 2016-09-25 Cytarabine+Methotrexate Intrathecal Y N 220033965 FLUDARABINE
220019818 220009017 -1 null null 2016-06-10 2016-08-02 EOX null N 220033984 VINCRISTINE
220019819 220009020 1.64 47.4 Curative (C) 2014-03-04 2014-05-20 FEC 100 N N 220033988 DACARBAZINE
220019820 220018094 1.76 55.4 null 2018-04-12 2018-07-11 DABRAFENIB N N 220033997 CYCLOPHOSPHAMIDE HIGH DOSE
220019821 220009028 1.73 46.7 Curative (C) 2017-07-31 2017-07-31 Trastuzumab Subcutaneous N N 220034002 WT1 TRIAL
220019822 220009030 1.8 62.2 Curative (C) 2017-03-23 2017-03-25 PEMBROLIZUMAB null N 220034012 EVEROLIMUS
220019823 220009032 1.52 71 Disease modification (D) 2015-10-30 2016-11-29 CETUXIMAB N N 220034022 ARSENIC TRIOXIDE + ATRA
220019824 220018097 1.72 null Palliative (P) 2016-07-02 2016-07-10 CAV N N 220034035 CAPECITABINE + OXALIPLATIN
220019825 220009038 1.87 85.5 Curative (C) 2018-11-24 2018-11-24 Carboplatin + Irinotecan 2 N 220034038 MIDAC
220019826 220009041 1.54 58 Curative (C) 2015-05-06 2015-05-20 VINORELBINE N N 220034055 ALEMTUZUMAB + FLUDARABINE
220019827 220009046 1.53 66.8 Curative (C) 2014-10-14 2014-12-25 CAPECITABINE + OXALIPLATIN 02 N 220034070 FLUOROURACIL
220019828 220009048 1.65 71 Curative (C) 2014-12-26 2014-12-26 MACE 01 N 220034076 BUSULPHAN + CYCLO
220019829 220009048 1.72 71.8 Curative (C) 2015-05-20 2015-05-20 Sorafenib null N 220034076 LENALIDOMIDE
220019830 220009052 1.65 null Curative (C) 2014-04-08 2014-04-12 PEMBROLIZUMAB N N 220034081 CYTARABINE IT + METHOTREXATE
220019831 220009061 1.8 null Curative (C) 2016-11-23 2016-11-24 Spanish Maintenance (Months 1-3) null null 220034115 VINCRISTINE
220019832 220009066 1.52 54.6 Disease modification (D) 2014-05-16 2014-05-20 MA (Cytarabine 3g/m2) 02 Y 220034117 TRASTUZUMAB
220019833 220009070 1.64 78.4 Curative (C) 2018-05-29 2018-06-28 VINORELBINE N N 220034127 FLA
220019834 220009073 1.73 78.3 Curative (C) 2018-02-14 2018-02-14 Cetuximab + FOLFIRI cycle1 N Y 220034132 ARSENIC TRIOXIDE + ATRA
220019835 220009080 1.67 61 Not known (9) 2016-06-10 2017-03-08 MELPHALAN Y N 220034156 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220019836 220009081 null 60.7 Palliative (P) 2018-09-12 2018-09-12 Cytarabine+Methotrexate Intrathecal N N 220034164 FLUDARABINE
220019837 220014845 1.51 76 Palliative (P) 2016-07-11 2016-09-28 GDCVP 02 null 220034194 CETUXIMAB
220019838 220009087 null null Curative (C) 2015-10-19 2015-11-02 EOX null N 220034195 BUSULFAN + CYCLOPHOSPHAMIDE
220019839 220009089 1.75 59 Curative (C) 2015-06-07 2015-07-08 MITOXANTRONE + TRETINOIN 02 N 220034214 ALEMTUZUMAB + FLUDARABINE
220019840 220009091 null 80 Curative (C) 2016-10-03 2017-02-02 Ipilimumab N null 220034218 ALL INTENSIFICATION
220019842 220014856 1.64 88.5 Curative (C) 2017-04-11 2017-08-05 CAMELLIA Trial N N 220034274 CISPLATIN + ETOPOSIDE
220019843 220019941 1.57 64.6 Curative (C) 2016-04-17 2016-05-15 Capecitabine 02 N 220034302 MACE
220019844 220014861 0 87 null 2016-05-19 2016-05-19 ATG + Busulfan + Fludarabine + Thiotepa 01 N 220034322 SORAFENIB
220019845 220009114 1.52 0 Curative (C) 2014-04-06 2014-04-06 Alemtuzumab+Busulfan+CyclophosphMUD 02 N 220034334 RAVVA TRIAL
220019846 220018115 1.76 74.4 Palliative (P) 2013-01-09 2013-07-30 ATG + BUSULFAN + CYCLOPHOSPHAMIDE 02 N 220034340 BUSULPHAN + CYCLO
220019847 220009118 1.77 76 Curative (C) 2014-02-23 2014-03-22 MITOMYCIN 02 N 220034346 CETUXIMAB + IRINOTECAN + MDG
220019848 220018117 1.7 null Neo-adjuvant (N) 2014-01-30 2014-02-06 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN N null 220034352 EOX
220019849 220009124 1.63 107.8 Curative (C) 2015-09-20 2015-10-07 CYTARABINE + FLUDARABINE 02 N 220034356 FLUOROURACIL
220019850 220009126 null 85 Not known (9) 2017-12-03 2017-12-04 ALEMTUZUMAB + FLUDARABINE null null 220034364 MYELOMA XI TRIAL
220019851 220009133 1.8 21.4 null 2015-04-16 2017-03-10 Cetuximab 14 day N N 220034423 CISPLATIN
220019852 220019943 0 76.6 Curative (C) null 2018-07-10 Cladribine (subcut) 5 days 02 N 220034424 CAPECITABINE
220019853 220009140 1.91 0 Disease modification (D) 2014-04-18 2015-09-11 MITOXANTRONE + TRETINOIN 2 N 220034425 GDCVP
220019854 220009141 1.67 null Curative (C) 2016-02-22 2017-11-29 MA (Cytarabine 3g/m2) N N 220034425 CETUXIMAB + CISPLATIN + FU
220019855 220009147 1.76 86.9 Curative (C) 2017-05-18 2017-05-18 Busulfan + Cyclophos Conditioning 02 N 220034440 DOXORUBICIN
220019856 220009148 1.8 78.3 Curative (C) 2016-07-31 2016-08-09 CAV N N 220034447 FIGARO TRIAL
220019858 220009153 1.7 67.3 Curative (C) 2017-04-07 2017-04-07 INTERFERON 02 N 220034482 INTERFERON
220019859 220009160 1.75 62.8 Curative (C) null 2014-09-12 TRASTUZUMAB N N 220034495 CLOFARABINE + CYTSARABINE + IDARUBICIN
220019860 220014883 1.77 78.9 Palliative (P) null 2013-11-19 Depocyte Intrathecal N N 220034505 TRASTUZUMAB
220019861 220014884 1.6 53 Palliative (P) 2019-07-26 2019-07-27 Fluorouracil + Folinic Acid Weekly N null 220034510 LIPOSOMAL CYTARABINE
220019862 220022218 1.75 67.3 Curative (C) 2014-01-25 2014-01-31 INTERFERON N null 220034521 CAPECITABINE
220019863 220009174 1.72 51 Disease modification (D) 2017-10-11 2017-10-22 DAUNORUBICIN null null 220034531 CARBOPLATIN
220019864 220014887 1.78 null null 2017-01-31 2017-01-31 Ipilimumab N N 220034543 CARBOPLATIN + VINORELBINE